Quarterly report pursuant to Section 13 or 15(d)

Abeona Therapeutics LLC Acquisition (Tables)

v3.2.0.727
Abeona Therapeutics LLC Acquisition (Tables)
6 Months Ended
Jun. 30, 2015
Abeona Therapeutics LLC Acquisition [Abstract]  
Schedule of purchase price allocation
Total purchase price
   
Initial consideration
 
$
31,758,000
 
Contingent consideration
   
6,489,000
 
Total purchase price
 
$
38,247,000
 
         
Allocation of the purchase price
       
Cash
 
$
3,697,000
 
Accounts receivable
   
1,000
 
Prepaid expenses
   
28,000
 
Property and equipment
   
51,000
 
Other assets
   
1,000
 
Accounts payable
   
(153,000
)
Total tangible assets
   
3,625,000
 
         
Licensing agreement
   
2,156,000
 
Goodwill
   
38,955,000
 
Contingent consideration liability (6,489,000 )
         
Total net asset value
 
$
38,247,000